Form 8-K - Current report:
SEC Accession No. 0001193125-25-056122
Filing Date
2025-03-18
Accepted
2025-03-18 07:15:21
Documents
56
Period of Report
2025-03-18
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d908678d8k.htm   iXBRL 8-K 30425
2 EX-99.1 d908678dex991.htm EX-99.1 52196
6 GRAPHIC g908678ex99_1p10g1.jpg GRAPHIC 155461
7 GRAPHIC g908678ex99_1p11g1.jpg GRAPHIC 156544
8 GRAPHIC g908678ex99_1p12g1.jpg GRAPHIC 416494
9 GRAPHIC g908678ex99_1p13g1.jpg GRAPHIC 316811
10 GRAPHIC g908678ex99_1p14g1.jpg GRAPHIC 356170
11 GRAPHIC g908678ex99_1p15g1.jpg GRAPHIC 200175
12 GRAPHIC g908678ex99_1p16g1.jpg GRAPHIC 286496
13 GRAPHIC g908678ex99_1p17g1.jpg GRAPHIC 135881
14 GRAPHIC g908678ex99_1p18g1.jpg GRAPHIC 418573
15 GRAPHIC g908678ex99_1p19g1.jpg GRAPHIC 418278
16 GRAPHIC g908678ex99_1p1g1.jpg GRAPHIC 179179
17 GRAPHIC g908678ex99_1p20g1.jpg GRAPHIC 255765
18 GRAPHIC g908678ex99_1p21g1.jpg GRAPHIC 123235
19 GRAPHIC g908678ex99_1p22g1.jpg GRAPHIC 437770
20 GRAPHIC g908678ex99_1p23g1.jpg GRAPHIC 459603
21 GRAPHIC g908678ex99_1p24g1.jpg GRAPHIC 328638
22 GRAPHIC g908678ex99_1p25g1.jpg GRAPHIC 126206
23 GRAPHIC g908678ex99_1p26g1.jpg GRAPHIC 383424
24 GRAPHIC g908678ex99_1p27g1.jpg GRAPHIC 263944
25 GRAPHIC g908678ex99_1p28g1.jpg GRAPHIC 148939
26 GRAPHIC g908678ex99_1p29g1.jpg GRAPHIC 474839
27 GRAPHIC g908678ex99_1p2g1.jpg GRAPHIC 786471
28 GRAPHIC g908678ex99_1p30g1.jpg GRAPHIC 332604
29 GRAPHIC g908678ex99_1p31g1.jpg GRAPHIC 369107
30 GRAPHIC g908678ex99_1p32g1.jpg GRAPHIC 115176
31 GRAPHIC g908678ex99_1p33g1.jpg GRAPHIC 443450
32 GRAPHIC g908678ex99_1p34g1.jpg GRAPHIC 333829
33 GRAPHIC g908678ex99_1p35g1.jpg GRAPHIC 349304
34 GRAPHIC g908678ex99_1p36g1.jpg GRAPHIC 125959
35 GRAPHIC g908678ex99_1p37g1.jpg GRAPHIC 324254
36 GRAPHIC g908678ex99_1p38g1.jpg GRAPHIC 516973
37 GRAPHIC g908678ex99_1p39g1.jpg GRAPHIC 509432
38 GRAPHIC g908678ex99_1p3g1.jpg GRAPHIC 357085
39 GRAPHIC g908678ex99_1p40g1.jpg GRAPHIC 125054
40 GRAPHIC g908678ex99_1p41g1.jpg GRAPHIC 262108
41 GRAPHIC g908678ex99_1p42g1.jpg GRAPHIC 372176
42 GRAPHIC g908678ex99_1p4g1.jpg GRAPHIC 333422
43 GRAPHIC g908678ex99_1p5g1.jpg GRAPHIC 444376
44 GRAPHIC g908678ex99_1p6g1.jpg GRAPHIC 361081
45 GRAPHIC g908678ex99_1p7g1.jpg GRAPHIC 364518
46 GRAPHIC g908678ex99_1p8g1.jpg GRAPHIC 217679
47 GRAPHIC g908678ex99_1p9g1.jpg GRAPHIC 332097
  Complete submission text file 0001193125-25-056122.txt   18713407

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA prme-20250318.xsd EX-101.SCH 2869
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE prme-20250318_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prme-20250318_pre.xml EX-101.PRE 11271
58 EXTRACTED XBRL INSTANCE DOCUMENT d908678d8k_htm.xml XML 3627
Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41536 | Film No.: 25746486
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)